SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort

Euglycemic diabetic ketoacidosis (EuDKA) secondary to Sodium-glucose co-transporter-2 inhibitors (SGLT2i) in type 2 diabetes mellitus (T2D) is a rare but increasingly reported phenomenon. Not much is known about the burden of EuDKA in patients on SGLT2i or the associated factors. This retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Ata, Fateen, Yousaf, Zohaib, Khan, Adeel Ahmad, Razok, Almurtada, Akram, Jaweria, Ali, Elrazi Awadelkarim Hamid, Abdalhadi, Ahmed, Ibrahim, Diaeldin Abdelgalil, Al Mohanadi, Dabia Hamad S. H., Danjuma, Mohammed I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119406/
https://www.ncbi.nlm.nih.gov/pubmed/33986421
http://dx.doi.org/10.1038/s41598-021-89752-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119406/
https://www.ncbi.nlm.nih.gov/pubmed/33986421
http://dx.doi.org/10.1038/s41598-021-89752-w

Ejemplares similares